Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening | |
Guo, Wei1,2; Yao, Sheng3,4; Sun, Pu1,2; Yang, Tian-biao4; Tang, Chun-ping3,4; Zheng, Ming-yue4; Ye, Yang3,4,5; Meng, Ling-hua1,2 | |
刊名 | ACTA PHARMACOLOGICA SINICA |
2020-03-01 | |
卷号 | 41期号:3页码:423-431 |
关键词 | indoleamine 2 3-dioxygenase 1 inhibitor natural product library high-throughput fluorescence-based screening |
ISSN号 | 1671-4083 |
DOI | 10.1038/s41401-019-0246-4 |
通讯作者 | Ye, Yang(yye@mail.shcnc.ac.cn) ; Meng, Ling-hua(lhmeng@simm.ac.cn) |
英文摘要 | Indoleamine 2,3-dioxygenase 1 (IDO1) is emerging as a promising therapeutic target for the treatment of malignant tumors characterized by dysregulated tryptophan metabolism. However, the antitumor efficacy of existing small-molecule IDO1 inhibitors is still unsatisfactory, and the underlying mechanism remains largely undefined. To identify novel IDO1 inhibitors, an in-house natural product library of 2000 natural products was screened for inhibitory activity against recombinant human IDO1. High-throughput fluorescence-based screening identified 79 compounds with inhibitory activity > 30% at 20 mu M. Nine natural products were further confirmed to inhibit IDO1 activity by > 30% using Ehrlich's reagent reaction. Compounds 2, 7, and 8 were demonstrated to inhibit IDO1 activity in a cellular context. Compounds 2 and 7 were more potent against IDO1 than TDO2 in the enzymatic assay. The kinetic studies showed that compound 2 exhibited noncompetitive inhibition, whereas compounds 7 and 8 were graphically well matched with uncompetitive inhibition. Compounds 7 and 8 were found to bind to the ferric-IDO1 enzyme. Docking stimulations showed that the naphthalene ring of compound 8 formed "T-shaped" pi-pi interactions with Phe-163 and that the 6-methyl-naphthalene group formed additional hydrophobic interactions with IDO1. Compound 8 was identified as a derivative of tanshinone, and preliminary SAR analysis indicated that tanshinone derivatives may be promising hits for the development of IDO1 inhibitors. This study provides new clues for the discovery of IDO1/TDO2 inhibitors with novel scaffolds. |
资助项目 | National Natural Science Foundation of China[81773760] ; National Natural Science Foundation of China[81573305] ; National Natural Science Foundation of China[81673327] ; International Partnership Program of the Chinese Academy of Sciences[153631KYSB20160004] |
WOS关键词 | TUMORAL IMMUNE RESISTANCE ; TRYPTOPHAN 2,3-DIOXYGENASE ; EXPRESSION ; MECHANISM ; IDENTIFICATION ; PURIFICATION ; DERIVATIVES ; ENZYMES ; DESIGN ; LIGAND |
WOS研究方向 | Chemistry ; Pharmacology & Pharmacy |
语种 | 英语 |
出版者 | NATURE PUBLISHING GROUP |
WOS记录号 | WOS:000514159600014 |
内容类型 | 期刊论文 |
源URL | [http://119.78.100.183/handle/2S10ELR8/281511] |
专题 | 中国科学院上海药物研究所 |
通讯作者 | Ye, Yang; Meng, Ling-hua |
作者单位 | 1.Chinese Acad Sci, Shanghai Inst Mat Med, Div Antitumor Pharmacol, Shanghai 201203, Peoples R China 2.Univ Chinese Acad Sci, Beijing 100049, Peoples R China 3.Chinese Acad Sci, Shanghai Inst Mat Med, Dept Nat Prod Chem, Shanghai 201203, Peoples R China 4.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China 5.ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201203, Peoples R China |
推荐引用方式 GB/T 7714 | Guo, Wei,Yao, Sheng,Sun, Pu,et al. Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening[J]. ACTA PHARMACOLOGICA SINICA,2020,41(3):423-431. |
APA | Guo, Wei.,Yao, Sheng.,Sun, Pu.,Yang, Tian-biao.,Tang, Chun-ping.,...&Meng, Ling-hua.(2020).Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening.ACTA PHARMACOLOGICA SINICA,41(3),423-431. |
MLA | Guo, Wei,et al."Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening".ACTA PHARMACOLOGICA SINICA 41.3(2020):423-431. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论